Lianjie Hou

3PUBLICATIONS
2CO-AUTHORS
Predictive and prognostic markersBiomechanics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Oct 31, 2023
Oridonin attenuates atherosclerosis by inhibiting foam macrophage formation and inflammation through FABP4/PPARγ signalling.

Ming Zhang, Lianjie Hou, Wanying Tang

|Oct 22, 2021
Dihydromyricetin resists inflammation-induced muscle atrophy via ryanodine receptor-CaMKK-AMPK signal pathway.

Lianjie Hou, Fangyi Jiang, Bo Huang

Pageof 1